Treatment Of Antibody Claims In The U.S. After Amgen v. Sanofi
The future of antibody claiming in the United States is uncertain following the U.S. Supreme Courts May 2023 ruling in Amgen Inc. v. Sanofi, 598 U.S. 594 , a highly anticipated decision concerning...
Source: marketscreener.com